Koninklijke DSM NV
AEX:DSM

Watchlist Manager
Koninklijke DSM NV Logo
Koninklijke DSM NV
AEX:DSM
Watchlist
Price: 114.05 EUR Market Closed
Market Cap: 568.6m EUR

Wall Street
Price Targets

DSM Price Targets Summary
Koninklijke DSM NV

There are no price targets for DSM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Koninklijke DSM NV Competitors:
Price Targets
014680
Hansol Chemical Co Ltd
64% Upside
3708
Swancor Holding Co Ltd
111% Upside
CLEAN
Clean Science and Technology Ltd
9% Upside
002643
Valiant Co Ltd
23% Upside
UMI
Umicore SA
21% Upside
4958
T.Hasegawa Co Ltd
38% Upside
ACT
AlzChem Group AG
8% Downside
5384
Fujimi Inc
58% Upside

Revenue
Forecast

Revenue Estimate
Koninklijke DSM NV

For the last 8 years the compound annual growth rate for Koninklijke DSM NV's revenue is 2%. The projected CAGR for the next 2 years is 17%.

2%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Koninklijke DSM NV

Operating Income forecast
is not available for
Koninklijke DSM NV

Net Income
Forecast

Net Income Estimate
Koninklijke DSM NV

For the last 8 years the compound annual growth rate for Koninklijke DSM NV's net income is 39%. The projected CAGR for the next 2 years is -34%.

39%
Past Growth
-34%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSM's stock price target?
Not Available

DSM doesn't have any price targets made by Wall Street professionals.

What is Koninklijke DSM NV's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Koninklijke DSM NV's revenue is 2%. The projected CAGR for the next 2 years is 17%.

What is Koninklijke DSM NV's Net Income forecast?
Projected CAGR
-34%

For the last 8 years the compound annual growth rate for Koninklijke DSM NV's net income is 39%. The projected CAGR for the next 2 years is -34%.

Back to Top